TMQ | Ticker Profile - Titan Protect

TMQ

Trilogy Metals Inc.

Basic Materials · Other Industrial Metals & Mining · ASE

$3.82

Data: 2026-05-28

✗ ETHICAL FAIL

Unknown MOAT

MODERATE

Data Confidence: 71.4%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$756M

Total market value of the company

Trailing P/E

N/A

Forward P/E

-54.98

Based on estimated future earnings — lower means cheaper

Rev Growth

N/A

Year-over-year revenue change

Profit Margin

0.0%

How much profit the company keeps from each dollar of revenue

ROE

-36.1%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$6.14

+61% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 3 analysts covering this stock

About Trilogy Metals Inc.

Trilogy Metals Inc. engages in the exploration and development of mineral properties in the United States. It primarily explores copper, cobalt, lead, zinc, gold, and silver properties. The company principally holds interests in the Upper Kobuk mineral projects that include the Arctic, which contains polymetallic volcanogenic massive sulfide deposits; and Bornite that contains carbonate-hosted copper-cobalt deposits covering an area of approximately 448,217 acres located in the Ambler mining district in Northwest Alaska. The company was formerly known as NovaCopper Inc. and changed its name to Trilogy Metals Inc. in September 2016. Trilogy Metals Inc. was founded in 2004 and is headquartered in Vancouver, Canada.

https://www.trilogymetals.com

Country: Canada Employees: 5 Industry: Other Industrial Metals & Mining

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% N/A

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

ACCUMULATION

Smart money appears to be building positions quietly

Sharpe Ratio

1.141

Excellent risk-adjusted returns

Kelly Fraction

0.0639

Suggested allocation is meaningful — the edge justifies a position

Calmar Ratio

2.839

Returns exceed worst-case losses — strong risk profile

Annual Return

197.7%

Historical annualised return based on price data

Max Drawdown

-69.6%

Largest peak-to-trough decline — the worst it has been

HMM State

BEAR

Statistical model detects bearish conditions

Days in State

134

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.65

Significantly more volatile than the market

52W High

$11.29

66% below the year high

52W Low

$1.17

226% above the year low

Avg Volume

2,760,314

Average daily shares traded — higher means easier to buy and sell

Short Ratio

2.7

Days it would take all short sellers to cover — higher means more crowded

Short % Float

7.1%

Moderate short interest

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$-0.28

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

0.09

Conservative use of debt — low financial risk

Current Ratio

1.46

Adequate but worth monitoring

Quick Ratio

1.46

Like current ratio but excludes inventory — stricter test

Gross Margin

0.0%

Revenue left after cost of goods — higher means pricing power

Operating Margin

0.0%

Profit from core operations before interest and tax

Free Cash Flow

$30M

Positive — the business generates more cash than it spends

Revenue (TTM)

N/A

Total revenue over the last 12 months

Net Income

$-45,681,000

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$9.94

Target Median

$6.14

Target Low

$5.41

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go